These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11434720)

  • 21. Sustained activation of the raf-MEK-ERK pathway elicits cytokine unresponsiveness in T cells.
    Chen D; Heath V; O'Garra A; Johnston J; McMahon M
    J Immunol; 1999 Dec; 163(11):5796-805. PubMed ID: 10570262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of T lymphocyte signal transduction through clonal anergy.
    Fields P; Fitch FW; Gajewski TF
    J Mol Med (Berl); 1996 Nov; 74(11):673-83. PubMed ID: 8956153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.
    Kriegel MA; Adam-Klages S; Gabler C; Blank N; Schiller M; Scheidig C; Kalden JR; Lorenz HM
    Int Immunol; 2008 Apr; 20(4):601-13. PubMed ID: 18310062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.
    Tsitoura DC; Holter W; Cerwenka A; Gelder CM; Lamb JR
    J Immunol; 1996 Apr; 156(8):2801-8. PubMed ID: 8609399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade.
    Rowell EA; Wang L; Hancock WW; Wells AD
    J Immunol; 2006 Oct; 177(8):5169-76. PubMed ID: 17015702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
    Boonen GJ; van Dijk AM; Verdonck LF; van Lier RA; Rijksen G; Medema RH
    Eur J Immunol; 1999 Mar; 29(3):789-98. PubMed ID: 10092081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-linking HLA-DR molecules on Th1 cells induces anergy in association with increased level of cyclin-dependent kinase inhibitor p27(Kip1).
    Kudo H; Matsuoka T; Mitsuya H; Nishimura Y; Matsushita S
    Immunol Lett; 2002 Apr; 81(2):149-55. PubMed ID: 11852120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes.
    Duré M; Macian F
    Mol Immunol; 2009 Feb; 46(5):999-1006. PubMed ID: 18990450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
    Chambers CA; Kuhns MS; Egen JG; Allison JP
    Annu Rev Immunol; 2001; 19():565-94. PubMed ID: 11244047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.
    Verhoef A; Lamb JR
    J Immunol; 2000 Jun; 164(11):6034-40. PubMed ID: 10820288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive tolerance and clonal anergy are distinct biochemical states.
    Chiodetti L; Choi S; Barber DL; Schwartz RH
    J Immunol; 2006 Feb; 176(4):2279-91. PubMed ID: 16455984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of T cell differentiation and alloimmunity by the cyclin-dependent kinase inhibitor p18ink4c.
    Rowell EA; Wang L; Chunder N; Hancock WW; Wells AD
    PLoS One; 2014; 9(3):e91587. PubMed ID: 24614758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype.
    Gajewski TF; Lancki DW; Stack R; Fitch FW
    J Exp Med; 1994 Feb; 179(2):481-91. PubMed ID: 8294862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coculture of Th cells with interleukin (IL)-7 in the absence of antigenic stimuli induced T-cell anergy reversed by IL-15.
    Chen YZ; Lai ZF; Nishimura Y
    Hum Immunol; 2005 Jun; 66(6):677-87. PubMed ID: 15993713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
    Colombetti S; Basso V; Mueller DL; Mondino A
    J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD3-induced anergy in cloned human Th0, Th1, and Th2 cells.
    Nguyen DD; Beck L; Spiegelberg HL
    Cell Immunol; 1995 Oct; 165(1):153-7. PubMed ID: 7671320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD40-mediated induction of p21 accumulation in resting and cycling B cells.
    Mullins MW; Pittner BT; Snow EC
    Mol Immunol; 1998 Jul; 35(10):567-80. PubMed ID: 9823756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of IL-5 production to the cAMP-dependent pathway in human T cells is reduced by exogenous IL-2 in a phosphoinositide 3-kinase-dependent way.
    Heijink IH; Kauffman HF; Postma DS; de Monchy JG; Vellenga E
    Eur J Immunol; 2003 Aug; 33(8):2206-15. PubMed ID: 12884295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.